Warning letter
Shield Technology Inc.: warning letter of Mar 16, 2000
FDA warning letter UCM068246 · Dallas District Office
Key facts
| Reference number | UCM068246 |
|---|---|
| Company | Shield Technology Inc. |
| Subject | Chimal/Starlee Skin Shields/Lack Approved New Drug Application |
| Issue date | Mar 16, 2000 |
| Posted date | Mar 16, 2000 |
| Issuing office | Dallas District Office |
| Product type | Drugs |
| Country | 3 |
| Inspection city | New Orleans |
| Inspection ZIP | 70125-1235 |
| Inspection start date | Oct 25, 1999 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: